Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Belantamab Mafodotin for Multiple Myeloma
Recruiting1 awardPhase 2
Jacksonville, Florida
This trial tests different doses and schedules of belantamab mafodtin to treat multiple myeloma that has come back or doesn't respond to treatment. It may help reduce side effects and treat patients better.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.